{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:29:30Z","timestamp":1785713370507,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011635","name":"Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital","doi-asserted-by":"publisher","award":["2022-GSP-TS-8"],"award-info":[{"award-number":["2022-GSP-TS-8"]}],"id":[{"id":"10.13039\/501100011635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34727","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T06:40:00Z","timestamp":1721112000000},"page":"e34727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["MYH7 mutation is associated with mitral valve leaflet elongation in patients with obstructive hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"10","author":[{"given":"Xinli","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changpeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e34727_bib1","first-page":"2733","article-title":"ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J 2014"},{"key":"10.1016\/j.heliyon.2024.e34727_bib2","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e34727_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e34727_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","article-title":"Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy","volume":"54","author":"Bos","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e34727_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12872-020-01807-4","article-title":"Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy","volume":"20","author":"Velicki","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.heliyon.2024.e34727_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001220","article-title":"Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers","volume":"7","author":"Adalsteinsdottir","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.heliyon.2024.e34727_bib7","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/eurheartj\/ehx527","article-title":"Women with hypertrophic cardiomyopathy have worse survival","volume":"38","author":"Geske","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2024.e34727_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cge.13027","article-title":"Genetics of hypertrophic cardiomyopathy: a review of current state","volume":"93","author":"Sabater-Molina","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.heliyon.2024.e34727_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00392-017-1155-5","article-title":"Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals","volume":"107","author":"Sedaghat-Hamedani","year":"2018","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e34727_bib10","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.heliyon.2024.e34727_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/eurjhf\/hfr074","article-title":"Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure","volume":"13","author":"Waldm\u00fcller","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e34727_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005311","article-title":"Lack of phenotypic differences by cardiovascular magnetic resonance imaging in MYH7 (\u03b2-myosin heavy chain)- versus MYBPC3 (Myosin-Binding protein C)-Related hypertrophic cardiomyopathy","volume":"10","author":"Weissler-Snir","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.heliyon.2024.e34727_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100641","article-title":"The role of mitral valve in hypertrophic obstructive cardiomyopathy: an updated review","volume":"46","author":"Sakellaropoulos","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e34727_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e34727_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12968-016-0250-5","article-title":"Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy","volume":"18","author":"Tarkiainen","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.heliyon.2024.e34727_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12947-019-0171-1","article-title":"Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy","volume":"17","author":"Chung","year":"2019","journal-title":"Cardiovasc. Ultrasound"},{"key":"10.1016\/j.heliyon.2024.e34727_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.heliyon.2024.e34727_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.heliyon.2024.e34727_bib19","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0735-1097(88)90207-0","article-title":"Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy","volume":"11","author":"Sasson","year":"1988","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e34727_bib20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/CIRCIMAGING.114.002411","article-title":"Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy","volume":"7","author":"Captur","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.heliyon.2024.e34727_bib21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/ehjci\/jey095","article-title":"Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers","volume":"19","author":"Groarke","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.heliyon.2024.e34727_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.gene.2015.09.008","article-title":"Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology","volume":"573","author":"Carrier","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.heliyon.2024.e34727_bib23","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy","volume":"128","author":"Marian","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e34727_bib24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12265-011-9319-6","article-title":"The mitral valve in hypertrophic cardiomyopathy: old versus new concepts","volume":"4","author":"Hag\u00e8ge","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.heliyon.2024.e34727_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ahj.2013.07.029","article-title":"Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy","volume":"166","author":"Marsiglia","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.heliyon.2024.e34727_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005191","article-title":"Incident atrial fibrillation is associated with MYH7 sarcomeric gene variation in hypertrophic cardiomyopathy","volume":"11","author":"Lee","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.heliyon.2024.e34727_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11010-023-04735-x","article-title":"MYH7 in cardiomyopathy and skeletal muscle myopathy","volume":"479","author":"Gao","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34727_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2018.12.012","article-title":"Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy - an ancillary study of the Portuguese registry of hypertrophic cardiomyopathy","volume":"278","author":"Lopes","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e34727_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133782","article-title":"Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy","volume":"5","author":"Helms","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.heliyon.2024.e34727_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101469","article-title":"Myocardial deformation analysis in MYBPC3 and MYH7 related sarcomeric hypertrophic cardiomyopathy-the Graz hypertrophic cardiomyopathy registry","volume":"12","author":"H\u00f6ller","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.heliyon.2024.e34727_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cvr\/cvu127","article-title":"Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations","volume":"103","author":"Witjas-Paalberends","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.heliyon.2024.e34727_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34727_bib33","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.109.935551","article-title":"In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction","volume":"122","author":"Kim","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e34727_bib34","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/01.CIR.85.5.1651","article-title":"Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy","volume":"85","author":"Klues","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e34727_bib35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jmbbm.2012.07.001","article-title":"Evidence of adaptive mitral leaflet growth","volume":"15","author":"Rausch","year":"2012","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.heliyon.2024.e34727_bib36","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.CIR.91.4.1189","article-title":"Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction","volume":"91","author":"Levine","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e34727_bib37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0003-4975(02)04546-0","article-title":"Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction","volume":"75","author":"Sherrid","year":"2003","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.heliyon.2024.e34727_bib38","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e34727_bib39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.athoracsur.2008.07.048","article-title":"Resection-plication-release for hypertrophic cardiomyopathy: clinical and echocardiographic follow-up","volume":"86","author":"Balaram","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.heliyon.2024.e34727_bib40","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.0000092912.57140.14","article-title":"Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy","volume":"108","author":"van der Lee","year":"2003","journal-title":"Circulation"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410758X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410758X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:02:21Z","timestamp":1773842541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402410758X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S240584402410758X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34727","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYH7 mutation is associated with mitral valve leaflet elongation in patients with obstructive hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34727"}}